Read & Publish agreement with the ZB Med Consortium
We are delighted to have signed a five journal Read & Publish agreement with ZB Med – Information Centre for Life Sciences in Germany from 1 January 2024 to 31 December 2026.
For a single annual charge, researchers at participating institutions benefit from:
- Unlimited access to all three of The Company of Biologists’ prestigious hybrid journals – Development, Journal of Cell Science and Journal of Experimental Biology – including the full archive dating back to 1853
- Uncapped, immediate and fee-free Open Access publishing of accepted articles by corresponding authors under CC BY licence terms in all three hybrid journals plus The Company of Biologists’ fully Open Access journals – Disease Models & Mechanisms and Biology Open.
This offer, which runs from 2024 to 2026, is available to 400 member institutions and 2,000 hospitals with discounted rates available depending on the number of participants.
Any questions? Contact us